CI

CeriBell, Inc.

CBLL·NASDAQ

$18.63

+6.5%
HealthcareMedical - Devices

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

At a Glance

Live Snapshot
Market Cap$706.87M
EPS-1.4600
P/E Ratio-12.76
Earnings Date08/04/2026

cbll

Cash and Cash Equivalents

Last Annual Value

40.48M

3-Year CAGR

-16%

5-Year CAGR

-10%

10-Year CAGR

-5%

CI

CeriBell, Inc. Competitors Analysis of Cash and Cash Equivalents

CBLL · NASDAQ
CompanyCash and Cash Equivalents
CAGR 3Y
CAGR 5Y
CAGR 10Y
CBLL logo
CeriBell, Inc.
NASDAQ:CBLL
40.48M
5.5%N/AN/A 
10.71M
-6.2%-36.8%N/A
118.21M
31.7%33.0%12.9%
150.49M
3.8%-18.7%N/A
EHAB logo
Enhabit, Inc.
NYSE:EHAB
43.60M
16.7%51.9%N/A
19.56M
-14.3%16.8%28.4%
21.64M
-45.5%-9.6%N/A
8.82M
-46.4%-25.1%30.4%
145.00M
-1.7%0.1%N/A
SRDX logo
Surmodics, Inc.
NASDAQ:SRDX
36.12M
-4.5%3.0%3.8%
CI

CeriBell, Inc. Fair Value Envelope

CBLL · NASDAQ

Our analysis suggests that CBLL has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $18.63, this represents a potential HIDDEN relative to our calculated worth for CeriBell, Inc..

Intrinsic Value
Current Price: $18.63